Research shows that prolactin, a hormone made by your pituitary gland, protects your liver from fat buildup by activating special brain cells that send signals through your nervous system to reduce fat production. According to Gram Research analysis, when prolactin was delivered directly to the brain in mice, it reduced liver fat much faster than when delivered to the body, suggesting the brain is the key control center for this process. This discovery could lead to new treatments for fatty liver disease, though human studies are still needed.
Scientists discovered that a hormone called prolactin, made by your pituitary gland, helps control how much fat builds up in your liver. According to Gram Research analysis, when prolactin sends signals to specific brain cells called POMC neurons, it triggers a chain reaction that tells your liver to burn fat instead of storing it. This finding could lead to new treatments for fatty liver disease, a condition affecting millions of people worldwide. The research used mice to show that prolactin works through the brain and nervous system, not directly on the liver itself, opening up entirely new ways to think about treating this common health problem.
Key Statistics
A 2026 research study published in Hepatology International found that mice lacking prolactin developed significantly more liver fat when fed a high-fat diet, demonstrating that prolactin is protective against fatty liver disease.
Prolactin injected directly into the brain reduced liver fat accumulation much more rapidly than the same hormone injected into the body, indicating the brain is the primary site where prolactin exerts its protective effects.
Removing prolactin receptors specifically from hypothalamic POMC neurons completely eliminated prolactin’s ability to prevent fatty liver disease in mice, proving these brain cells are essential for the hormone’s protective mechanism.
Central prolactin administration suppresses FASN-mediated fat production in the liver through enhanced sympathetic nervous system signaling, revealing a novel brain-liver circuit for controlling lipid metabolism.
The Quick Take
- What they studied: How a hormone called prolactin controls whether your liver stores or burns fat, and which brain cells are involved in this process.
- Who participated: Laboratory mice, including normal mice, mice without prolactin, and mice with specific brain cell modifications. The study also used brain tissue samples and liver cells grown in the lab.
- Key finding: Prolactin activates special brain cells (POMC neurons) that send signals through the nervous system to the liver, telling it to reduce fat production. When prolactin was given directly to the brain, it worked much faster at reducing liver fat than when given to the body.
- What it means for you: This research suggests that future treatments for fatty liver disease might work by boosting prolactin signals in the brain rather than treating the liver directly. However, this is early-stage research in mice, and human studies are needed before any new treatments become available.
The Research Details
Researchers used multiple approaches to understand how prolactin affects the liver. First, they studied mice that couldn’t make prolactin and compared them to normal mice fed a high-fat diet. They found that mice without prolactin developed worse fatty liver disease. Next, they used genetic techniques to remove prolactin receptors (the “receiving stations” for prolactin) specifically from POMC brain cells. This showed that these particular brain cells are essential for prolactin’s protective effect against fatty liver.
The team also injected prolactin directly into the brain (through a technique called intracerebroventricular injection) and compared it to injecting prolactin into the body. The brain injection worked much faster and more effectively at reducing liver fat. They used advanced techniques like electrophysiology (measuring electrical activity in brain cells), genetic sequencing (RNA-seq), and immunofluorescence (special staining to visualize cells) to understand exactly how prolactin activates these brain cells.
Finally, they traced the nerve pathway from the brain to the liver and showed that the sympathetic nervous system (the “fight or flight” system) carries the signal that tells the liver to stop making fat. They even blocked this nerve pathway to confirm it was essential for prolactin’s effects.
This research approach is important because it reveals that the brain, not just the liver itself, controls how much fat accumulates in liver tissue. By studying the specific brain cells and nerve pathways involved, scientists can identify new targets for treatment that might be more effective than drugs that work directly on the liver. Understanding the mechanism also helps explain why some people are more prone to fatty liver disease and could lead to personalized treatments.
This study used multiple complementary techniques (genetic, pharmacological, electrophysiological, and molecular) to confirm findings, which strengthens confidence in the results. The use of both genetic knockout mice and pharmacological interventions provides strong evidence for cause-and-effect relationships. However, all experiments were conducted in mice, so results may not directly translate to humans. The study was published in a peer-reviewed journal, indicating it passed expert review. The specific sample sizes for each experiment were not detailed in the abstract, which is a limitation for assessing statistical power.
What the Results Show
The research revealed a previously unknown pathway by which prolactin protects the liver from fat accumulation. Mice lacking prolactin developed significantly more liver fat when fed a high-fat diet compared to normal mice, demonstrating that prolactin is protective. When researchers removed prolactin receptors specifically from POMC brain neurons, the protective effect disappeared entirely, proving these brain cells are essential.
Central administration of prolactin (injected directly into the brain) reduced liver fat much more rapidly and effectively than peripheral administration (injected into the body). This finding was surprising and suggests that the brain is the primary site where prolactin exerts its anti-fat effects. The mechanism involves prolactin activating POMC neurons, which increases their electrical activity and causes them to send stronger signals through the sympathetic nervous system to the liver.
Once these signals reach the liver, they suppress a key enzyme called FASN (fatty acid synthase) that is responsible for creating new fat molecules. By reducing FASN activity, the liver produces less fat and maintains healthier lipid levels. The researchers confirmed this pathway by blocking the sympathetic nerves connecting the brain to the liver, which eliminated prolactin’s protective effects.
The study showed that prolactin specifically enhances the excitability of POMC neurons without affecting other nearby brain cells, indicating a selective and targeted mechanism. RNA sequencing revealed specific genes that are activated in POMC neurons when prolactin binds to its receptor, providing molecular evidence for the activation process. The research also demonstrated that this brain-liver communication pathway is particularly important during high-fat diet conditions, when the liver is under metabolic stress.
Previous research knew that prolactin affects metabolism, but this is the first study to clearly show that it works through specific brain cells to control liver fat. Earlier work focused on prolactin’s direct effects on various tissues, but this research shifts the understanding to a brain-centered mechanism. The discovery of the POMC neuron pathway adds to growing evidence that the brain plays a central role in controlling liver health, complementing other known brain-liver circuits involving different hormones and neurotransmitters.
The study was conducted entirely in mice, and the prolactin system may work differently in humans. The abstract does not provide specific sample sizes for each experiment, making it difficult to assess statistical power. The research used genetic and pharmacological manipulations that may not perfectly reflect natural changes in prolactin levels. Long-term effects of sustained prolactin signaling were not explored. The study focused on high-fat diet-induced fatty liver disease and may not apply to other causes of liver fat accumulation. Human clinical trials would be necessary to determine if these findings can be translated into effective treatments.
The Bottom Line
Based on this research, prolactin-based therapies targeting brain POMC neurons may become a future treatment option for fatty liver disease (MASLD). However, this is preliminary research in mice, and no clinical recommendations can be made at this time. Current evidence-based approaches for fatty liver disease remain diet modification, weight loss, and exercise. Individuals with fatty liver disease should consult their healthcare provider about proven treatments rather than waiting for prolactin-based therapies to be developed.
This research is most relevant to people with metabolic dysfunction-associated fatty liver disease (MASLD), previously called non-alcoholic fatty liver disease. It may also interest individuals at risk for fatty liver disease due to obesity, diabetes, or metabolic syndrome. Healthcare providers and pharmaceutical researchers should pay attention to this work as it opens new therapeutic avenues. The general public should understand that this is basic research that may eventually lead to new treatments, but practical applications are years away.
This is early-stage research, and realistic timelines for human treatments are 5-10 years or more. Researchers must first conduct additional animal studies to confirm safety and efficacy, then move to human clinical trials, which typically take several years. Even if a prolactin-based therapy is developed, it would need regulatory approval before becoming available to patients. In the meantime, proven lifestyle interventions remain the most effective approach for managing fatty liver disease.
Frequently Asked Questions
What is prolactin and why does it matter for liver health?
Prolactin is a hormone made by your pituitary gland that controls liver fat accumulation through brain signaling. Research shows that prolactin activates specific brain cells that send signals to reduce fat production in the liver, protecting against fatty liver disease.
How does the brain control liver fat if prolactin is a hormone?
Prolactin binds to receptors on POMC brain neurons, activating them to send electrical signals through the sympathetic nervous system to the liver. These nerve signals tell the liver to reduce production of new fat molecules, maintaining healthy lipid levels.
Can I increase my prolactin levels to treat fatty liver disease?
This research is preliminary and conducted only in mice. No human treatments based on prolactin are currently available. Proven approaches for fatty liver disease include weight loss, reducing dietary fat, increasing physical activity, and consulting your healthcare provider about your specific situation.
When will prolactin-based treatments for fatty liver disease be available?
This is early-stage research, and realistic timelines for human treatments are 5-10 years or more. Researchers must conduct additional animal studies and human clinical trials before any new therapies could be approved and made available to patients.
Does this research apply to people or just mice?
This study was conducted in mice, and results may not directly translate to humans. The prolactin system may work differently in people. Human clinical trials are necessary to determine if these findings can lead to effective treatments for people with fatty liver disease.
Want to Apply This Research?
- Track daily dietary fat intake (grams per day) and weekly liver health markers if available through medical testing. Users can log high-fat meals and monitor how dietary changes correlate with energy levels and metabolic markers over 8-12 week periods.
- Users can set a goal to reduce high-fat food consumption and increase physical activity, which activates the sympathetic nervous system naturally. The app could provide notifications about foods high in saturated fat and suggest lower-fat alternatives, helping users make choices that support liver health.
- Establish a baseline of current diet and activity patterns, then track changes weekly. Users should monitor for improvements in energy, weight, and metabolic markers (if available through connected health devices or medical tests). Long-term tracking over 3-6 months helps identify patterns and sustains behavior change.
This research is preliminary and was conducted in mice. The findings have not been tested in humans, and no clinical treatments based on this work are currently available. This article is for educational purposes only and should not be considered medical advice. If you have fatty liver disease or concerns about your liver health, consult with a qualified healthcare provider about evidence-based treatment options. Do not attempt to modify prolactin levels or pursue any experimental treatments without medical supervision.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.